Related Experiment Video
Updated: Feb 14, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
Kehinde O Obamiro1, Leanne Chalmers1, Kenneth Lee1
1Pharmacy, School of Medicine, University of Tasmania, Tasmania, Australia.
Insights
Patients with atrial fibrillation (AF) taking oral anticoagulants (OACs) show knowledge gaps, particularly those on direct-acting oral anticoagulants (DOACs). Improving patient education on anticoagulation therapy is crucial for better treatment outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Patient Education
Background:
- Atrial fibrillation (AF) is a common arrhythmia with significant health and economic impacts.
- Anticoagulants are vital for preventing stroke and systemic embolism in AF patients.
- Patient knowledge of anticoagulation therapy influences treatment efficacy and outcomes.
Purpose of the Study:
- To assess anticoagulation knowledge levels in AF patients using oral anticoagulants (OACs).
- To identify patient-related factors associated with OAC knowledge.
- To compare knowledge between warfarin and direct-acting oral anticoagulant (DOAC) users.
Main Methods:
- An online survey was administered to recruit participants.
- Validated tools, including the Anticoagulation Knowledge Tool, were used.
- Patient-related factors and medication adherence were assessed.
Main Results:
- Warfarin users demonstrated higher anticoagulation knowledge scores than DOAC users (73% ± 13% vs. 66% ± 14%).
- Key predictors of knowledge included age, OAC type, health information overload, and perceived ease of use.
- Beliefs about bleeding side effects differed significantly between warfarin and DOAC groups.
Conclusions:
- Significant knowledge gaps exist in AF patients on OACs, with DOAC users showing greater deficiencies.
- Integrating knowledge assessments into patient counseling is recommended to address deficits.
- Enhanced patient education can improve understanding and adherence to anticoagulation therapy.
Background:
Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia in clinical practice, and is associated with a significant medical and economic burden. Anticoagulants reduce the risk of stroke and systemic embolism by approximately two-thirds compared with no therapy. Knowledge regarding anticoagulant therapy can influence treatment outcomes in patients with AF.
Objective:
To measure the level of anticoagulation knowledge in patients with AF taking oral anticoagulants (OACs), investigate the association between patient-related factors and anticoagulation knowledge, and compare these results in patients taking warfarin and direct-acting oral anticoagulant (DOACs).
Methods:
Participants were recruited for an online survey via Facebook. Survey components included the Anticoagulation Knowledge Tool, the Perception of Anticoagulant Treatment Questionnaires (assessing treatment expectations, convenience and satisfaction), a modified Cancer Information Overload scale and the Morisky Medication Adherence Scale. Treatment groups were compared and predictors of OAC knowledge were identified.
Results:
Participants taking warfarin had a higher knowledge score compared with those taking DOACs (n = 386, 73% ± 13% vs 66% ± 14%, P<.001). Advancing age, type of OAC, health information overload and ease of OAC use (treatment expectation) were significant predictors of knowledge. Treatment expectation, including the belief that OAC treatment would cause bleeding side effects, varied significantly between participants taking warfarin and DOACs (P = .011).
Conclusion:
The study identified knowledge gaps in patients taking OACs, and these deficiencies appeared to be greater in participants taking DOACs. Knowledge assessment should be integrated into patient counselling sessions to help identify and resolve knowledge deficits.
Related Concept Videos
Surveys
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Introduction to Surveying, Plane Surveying and Geodetic Surveys
Errors and Mistakes in Surveying

